SkinBioTherapeutics Plc (SBTX.L) Stock Price
£16.63 2.3%
to add to portfolio
AI Score
-
Alternative
1 -
Fundamental
7 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on SkinBioTherapeutics Plc, AI stock picks, stock alerts and much more.
SBTX.L AI Stock Analysis
AI stock analysis for SBTX.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like SkinBioTherapeutics Plc (SBTX.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
SkinBioTherapeutics Plc (SBTX.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of SkinBioTherapeutics Plc (SBTX.L), currently trading at £16.63, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SBTX.L
-
SkinBioTherapeutics plc, a life science company, engages in the research and development of technology that harnesses the human microbiome to improve health.
-
Symbol
SBTX.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
38.9M
Similar Stocks
 |
Codexis 0I0X.L |
$2.25 0.4% |
4 |
 |
Oxford Nanopore Technologies plc ONT.L |
£119.5 0.8% |
5 |
 |
Sareum Holdings SAR.L |
£15.75 8.6% |
5 |
 |
Viridian Therapeutics 0K1R.L |
$14.77 5.9% |
6 |
 |
Avacta Group Plc AVCT.L |
£30 4.8% |
2 |
News
SBTX.L Alternative Data
Web Traffic
SkinBioTherapeutics Plc receives an estimated 509 monthly visitors to skinbiotherapeutics.com.
-
Web Traffic
509
-
Change from Previous Month
76.5%
-
3 Month Change
81.1%
-
YoY Change
81.1%
Facebook Engagement
SkinBioTherapeutics Plc has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
SkinBioTherapeutics Plc currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
SkinBioTherapeutics Plc has 439 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
439
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.7%
-
YoY Change
0.7%
LinkedIn Employees
According to LinkedIn, SkinBioTherapeutics Plc has 14 employees.
-
LinkedIn Employees
14
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
16.7%
Reddit Mentions
SkinBioTherapeutics Plc has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
SkinBioTherapeutics Plc was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
SBTX.L Financials
SBTX.L Key Metrics
-
Total Revenue
£1.6M
-
Net Income
-£1M
-
Earnings per Share
-£0.0046
-
Free cash flow
-£805.9K
-
EBITDA
-£881.2K
-
EBITDA Ratio
-0.558944
-
Total Assets
£7.3M
SBTX.L 2-year Revenue & Income
SBTX.L 2-year Free Cash Flow
SBTX.L Technicals
SBTX.L SMA
SBTX.L RSI
FAQ
What's the current price of SkinBioTherapeutics Plc (SBTX.L) Stock?
The price of an SkinBioTherapeutics Plc (SBTX.L) share is £16.63.
What's the market cap of SkinBioTherapeutics Plc?
The current market cap of SkinBioTherapeutics Plc is 38.9M.
Should I buy or sell SBTX.L?
SkinBioTherapeutics Plc exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is SkinBioTherapeutics Plc a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in SkinBioTherapeutics Plc stock. There are several bearish signals and market challenges that could negatively impact SkinBioTherapeutics Plc's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy SkinBioTherapeutics Plc (SBTX.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy SkinBioTherapeutics Plc stock right now, as the outlook appears bearish.
What are some stocks similar to SkinBioTherapeutics Plc (SBTX.L) that investors often compare it to?
SkinBioTherapeutics Plc (SBTX.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for SkinBioTherapeutics Plc's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast SkinBioTherapeutics Plc's stock price to be around £15.6 in 2026. Starting from the current price of £16.63, this represents a 6.2% change in price, indicating a bearish outlook for the stock.
How to buy SkinBioTherapeutics Plc (SBTX.L) Stock?
SkinBioTherapeutics Plc stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy SkinBioTherapeutics Plc shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.